Freedom Meditech, Inc. Establishes Diabetes R&D Operations in Ohio

Published: Feb 12, 2008

SAN DIEGO & CLEVELAND--(BUSINESS WIRE)--Freedom Meditech, Inc., a San Diego-based developer of a non-invasive ocular glucose measurement technology for people with diabetes, today announced the opening of new research and development (R&D) operations in Ohio. The new R&D operation leverages a product development services agreement with Cleveland-based MAGNET, Inc., and existing engineering and Food and Drug Administration (FDA) clinical trial expertise and resources available in Ohio.

Back to news